Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FWP

Forward Pharma A/S (FWP) Stock Price, News & Analysis

Forward Pharma A/S logo

About Forward Pharma A/S Stock (NASDAQ:FWP)

Advanced Chart

Key Stats

Today's Range
$1.95
$1.95
50-Day Range
$1.79
$3.19
52-Week Range
$1.50
$6.48
Volume
N/A
Average Volume
7,484 shs
Market Capitalization
$13.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Receive FWP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

FWP Stock News Headlines

Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Firebrick Pharma’s Strategic Moves Boost Market Position
See More Headlines

FWP Stock Analysis - Frequently Asked Questions

Forward Pharma A/S (NASDAQ:FWP) posted its earnings results on Thursday, September, 1st. The biotechnology company reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.26) by $0.06.

Based on aggregate information from My MarketBeat watchlists, some other companies that Forward Pharma A/S investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Akari Therapeutics (AKTX), Aldeyra Therapeutics (ALDX) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
9/01/2016
Today
5/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FWP
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$10.09 per share
Price / Book
0.19

Miscellaneous

Free Float
2,023,000
Market Cap
$13.83 million
Optionable
Not Optionable
Beta
1.38

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:FWP) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners